Cellivate

Cellivate is a healthcare company in Singapore, Singapore, founded in 2024. It has raised $1.0M across 1 round, most recently a $1.0M Seed in August 2024.

Solving bottlenecks faced by cell-based companies at different stages of the value chain

Headquarters
Singapore
Employees
1–10
Founded
2024
Business Model
B2B
Total Funding
$1.0M
Last Round
$1.0M SeedAug 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.

About

Cellivate Technologies is a National University of Singapore spin-off that develops animal-free, proprietary cell culture products. Its flagship BOOSTER product delivers controlled extracellular vesicle-mediated signaling to replace fetal bovine serum, reducing batch-to-batch variability for pharmaceutical, cultivated meat, cosmetics, and biotech applications.

Summary

It lists 1–10 employees. It has raised $1.0M in total across 1 round, most recently a $1.0M Seed round in Aug 2024. Investors include Venture Catalysts, HATCHER+ and Waterbridge Ventures.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundAug 2024
$1.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cellivate on Indexed.vc
<a href="https://indexed.vc/companies/cellivate"><img src="https://indexed.vc/api/badge/company/cellivate" alt="Cellivate on Indexed.vc" width="260" height="76" /></a>